A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Artios Pharma Ltd
Artios Pharma Ltd
GI Innovation, Inc.
PMV Pharmaceuticals, Inc
Mayo Clinic
Eikon Therapeutics
Essen Biotech
Essen Biotech
DualityBio Inc.
Second Life Therapeutics
Ocellaris Pharma, Inc.
Hadassah Medical Organization
Incyclix Bio
National Cancer Institute (NCI)
Incyte Corporation
Incyte Corporation
Yuhan Corporation
NuCana plc
NextCure, Inc.
Deciphera Pharmaceuticals, LLC
NextCure, Inc.
Salubris Biotherapeutics Inc
NantCell, Inc.
NantCell, Inc.
NextCure, Inc.
Avenge Bio, Inc
NextCure, Inc.
Capital Medical University
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
NKGen Biotech, Inc.
University of Maryland, Baltimore
National Institutes of Health Clinical Center (CC)
Adaptimmune
National Institutes of Health Clinical Center (CC)
MEI Pharma, Inc.
National Institutes of Health Clinical Center (CC)
Rutgers, The State University of New Jersey
Clavis Pharma